Serge Depatie is a vice president, portfolio manager and security analyst at Natcan Investment Management Inc., which he joined in 2003. Mr. Depatie began his investment career in 1999. From 1994 to 1999, he acted as Medical Products Development Director of CQI-Biomed and Marketing and Sales Vice President of Biosyntech. Before arriving at Natcan, he also worked for Hampton Securities and Jitney Group as Life Science Analyst. Mr. Depatie obtained an MBA degree from Concordia University and a BS degree in Engineering from McGill University.
Outlook For Global Healthcare Companies - Serge Depatie - Natcan Investment Management Inc.
October 19, 2009